.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Accenture
QuintilesIMS
McKesson
Deloitte
Mallinckrodt
Federal Trade Commission
Novartis
Cantor Fitzgerald
Moodys

Generated: June 27, 2017

DrugPatentWatch Database Preview

MS CONTIN Drug Profile

« Back to Dashboard

Which patents cover Ms Contin, and when can generic versions of Ms Contin launch?

Ms Contin is a drug marketed by Purdue Pharma Lp and is included in one NDA.

The generic ingredient in MS CONTIN is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for Tradename: MS CONTIN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list9
Clinical Trials: see list10
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MS CONTIN at DailyMed

Pharmacology for Tradename: MS CONTIN

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-003Sep 12, 1989ABRXYesNo► Subscribe► Subscribe
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-004Jan 16, 1990ABRXYesYes► Subscribe► Subscribe
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-001May 29, 1987ABRXYesNo► Subscribe► Subscribe
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-002Apr 8, 1988ABRXYesNo► Subscribe► Subscribe
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-005Nov 8, 1993ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MS CONTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-004Jan 16, 19904,366,310► Subscribe
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-003Sep 12, 19894,366,310► Subscribe
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-002Apr 8, 19884,366,310► Subscribe
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-005Nov 8, 19934,366,310► Subscribe
Purdue Pharma Lp
MS CONTIN
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL019516-001May 29, 19874,366,310► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Covington
Fish and Richardson
Accenture
Moodys
Boehringer Ingelheim
Cipla
UBS
Julphar
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot